DE69526918D1 - Arzneimittel gegen spinocerebellare degeneration - Google Patents

Arzneimittel gegen spinocerebellare degeneration

Info

Publication number
DE69526918D1
DE69526918D1 DE69526918T DE69526918T DE69526918D1 DE 69526918 D1 DE69526918 D1 DE 69526918D1 DE 69526918 T DE69526918 T DE 69526918T DE 69526918 T DE69526918 T DE 69526918T DE 69526918 D1 DE69526918 D1 DE 69526918D1
Authority
DE
Germany
Prior art keywords
represent
spinocerebellar degeneration
medicine against
ococh3
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69526918T
Other languages
English (en)
Other versions
DE69526918T2 (de
Inventor
Tetsuo Sakai
Yasunobu Antoku
Toyojiro Matsuishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asubio Pharma Co Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of DE69526918D1 publication Critical patent/DE69526918D1/de
Application granted granted Critical
Publication of DE69526918T2 publication Critical patent/DE69526918T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69526918T 1994-08-05 1995-08-04 Arzneimittel gegen spinocerebellare degeneration Expired - Lifetime DE69526918T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18468294 1994-08-05
PCT/JP1995/001550 WO1996003989A1 (fr) 1994-08-05 1995-08-04 Remede contre la degenerescence spino-cerebelleuse

Publications (2)

Publication Number Publication Date
DE69526918D1 true DE69526918D1 (de) 2002-07-11
DE69526918T2 DE69526918T2 (de) 2002-12-19

Family

ID=16157531

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69526918T Expired - Lifetime DE69526918T2 (de) 1994-08-05 1995-08-04 Arzneimittel gegen spinocerebellare degeneration

Country Status (6)

Country Link
US (1) US5753656A (de)
EP (1) EP0722731B1 (de)
AT (1) ATE218345T1 (de)
DE (1) DE69526918T2 (de)
ES (1) ES2177654T3 (de)
WO (1) WO1996003989A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418097A1 (de) 1994-05-24 1995-11-30 Cassella Ag Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase
WO1998004558A1 (fr) * 1996-07-31 1998-02-05 Artemis, Inc. Piegeurs d'oxygene actifs a base de derives de pterine
KR100650962B1 (ko) 1996-08-30 2007-07-18 다이이치 아스비오파마 가부시키가이샤 질소산화물합성효소(nos)의기능저하에의해유발되는질환의예방또는치료제
JP4306825B2 (ja) 1998-02-27 2009-08-05 アスビオファーマ株式会社 インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤
US7167844B1 (en) 1999-12-22 2007-01-23 Accenture Llp Electronic menu document creator in a virtual financial environment
US7610233B1 (en) 1999-12-22 2009-10-27 Accenture, Llp System, method and article of manufacture for initiation of bidding in a virtual trade financial environment
US6623754B2 (en) * 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
US20060110325A1 (en) * 2003-02-21 2006-05-25 Hinz Martin C Serotonin and catecholamine segment optimization technology
US20090311795A1 (en) * 2002-03-21 2009-12-17 Hinz Martin C Bilateral control of functions traditionally regulated by only serotonin or only dopamine
US20070293571A1 (en) * 2006-06-08 2007-12-20 Hinz Martin C Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
CA2479218A1 (en) * 2002-03-21 2003-10-02 Martin C. Hinz Serotonin and catecholamine system segment optimization technology
DE10260263A1 (de) * 2002-12-20 2004-07-15 Biocrates Life Sciences Gmbh Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
CA2543315A1 (en) * 2003-11-13 2005-06-02 The General Hospital Corporation Methods for treating pain
PL1708690T3 (pl) 2003-11-17 2017-01-31 Biomarin Pharmaceutical Inc. Leczenie fenyloketonurii za pomocą BH4
JP4964587B2 (ja) * 2004-05-11 2012-07-04 第一三共株式会社 Ｂｈ４反応性高フェニルアラニン血症治療剤
EP2436379A1 (de) 2004-11-17 2012-04-04 BioMarin Pharmaceutical Inc. Stabile Tablettenformulierung
AU2005313940A1 (en) * 2004-12-08 2006-06-15 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of pulmonary hypertension of the newborn
EP1965803A1 (de) * 2005-12-05 2008-09-10 Biomarin Pharmaceutical Inc. Verfahren und zusammensetzungen zur behandlung von krankheiten
JP2010515747A (ja) * 2007-01-12 2010-05-13 ビオマリン プハルマセウトイカル インコーポレイテッド テトラヒドロビオプテリンプロドラッグ
WO2008089148A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Method of treating a metabolic or neuropsychiatry disorder with a bh4 derivative prodrug
JP2010523708A (ja) 2007-04-11 2010-07-15 バイオマリン ファーマシューティカル インコーポレイテッド テトラヒドロビオプテリンを投与する方法、関連する組成物および測定方法
EP2224927B1 (de) * 2008-01-03 2014-08-20 BioMarin Pharmaceutical Inc. Pterin-analogon zur behandlung eines auf bh4 ansprechenden zustands
WO2011132435A1 (ja) 2010-04-22 2011-10-27 学校法人日本大学 脳機能障害予防・改善用の薬剤及び飲食物
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
AU2018277981B2 (en) * 2017-06-02 2021-04-08 Fujifilm Toyama Chemical Co., Ltd. Agent for preventing or treating spinocerebellar ataxia
KR20210038848A (ko) * 2018-05-30 2021-04-08 피티씨 테라퓨틱스 엠피, 인크. 세피아프테린의 제약상 허용되는 염

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925323A (ja) * 1982-03-03 1984-02-09 鐘淵化学工業株式会社 プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤
JPS5976086A (ja) * 1982-09-20 1984-04-28 ザ　ウエルカム　フアウンデ−シヨン　リミテツド プテリジン化合物
JPS61277618A (ja) 1985-06-04 1986-12-08 Suntory Ltd 自閉症治療剤
JP2588191B2 (ja) * 1987-04-24 1997-03-05 サントリー株式会社 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
ATE180493T1 (de) * 1991-11-16 1999-06-15 Suntory Ltd Rezeptor für 6(r)-l-erythro-5,6,7,8- tetrahydrobiopterin

Also Published As

Publication number Publication date
EP0722731B1 (de) 2002-06-05
ES2177654T3 (es) 2002-12-16
ATE218345T1 (de) 2002-06-15
EP0722731A1 (de) 1996-07-24
WO1996003989A1 (fr) 1996-02-15
DE69526918T2 (de) 2002-12-19
US5753656A (en) 1998-05-19
EP0722731A4 (de) 1998-03-04

Similar Documents

Publication Publication Date Title
DE69526918D1 (de) Arzneimittel gegen spinocerebellare degeneration
EP1036794A4 (de) 2-aryl-8-oxodihydropurin-derivate, ihre herstellung, ihre verwendung als medikamentenkomponente und deren intermediate
AU8794291A (en) New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them
WO2001072728A3 (en) Novel piperazine derivatives
AU7278500A (en) Fungicides
AU1608692A (en) Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants
PT928788E (pt) Compostos farmaceuticamente activos
ES2072223B1 (es) Liposomas encapsulando doxorubicina.
CA2336412A1 (en) Medicament for treatment of diabetes
IL166513A0 (en) Lamellarin derivatives and pharmaceutical compositions containing the same
WO2001021608A3 (en) Novel flavonoids
EP1182193A4 (de) Medikamente gegen neuropathische schmerzen
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
EP0754683A4 (de) Etherverbindungen, ihre verwendung und zwischenprodukte zu ihrer herstellung
WO2000046210A3 (en) New process for preparing pesticidal intermediates
DE602004007181D1 (de) 2,4,6-tris(4'aminobenzaldineopentylmalonat)-s-triazin, dieser enthaltenden Sonnenschutzzusammensetzungen und dessen Verwendungen
ATE241980T1 (de) Neue inhalationspräparate enthaltend cr 2039 (andolast)
FI911138A0 (fi) Ny substituerad aminfoerening och foerfarande foer dess framstaellning.
EP1026162A4 (de) Antirheumatika
DE69925225D1 (de) Propylaxe und behandlung der arzneimittel induzierten nierenstörungen
MX9206930A (es) Nuevos compuestos
AU4732096A (en) Remedy for pulmonary heart
EP0816366A4 (de) Imidazothiazolverbindungen
EP0358091A3 (de) 2-Zyklohexylpropanal-Derivate und diese enthaltende Parfümeriezusammenstellungen

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: DAICHI SUNTORY PHARMA CO., LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI ASUBIO PHARMA CO., LTD., TOKIO/TOKYO, JP

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASUBIO PHARMA CO., LTD., TOKYO, JP